Trial | NCT02245698  Report issue

Title

Autologous Stem Cell Therapy in Stroke
Autologous Bone Marrow Mononuclear Cells Intrathecal Transplantation in Stroke

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Withdrawn

  • Study Participants

    0
The purpose of this study was to study the safety and effect of stem cell therapy on the functional recovery in patients with sub acute/chronic stroke.
Study Started
Dec 31
2008
Primary Completion
Jun 30
2018
Anticipated
Study Completion
Dec 31
2018
Anticipated
Last Update
Oct 25
2018

Biological Stem cell

Intrathecal autologous bone marrow mononuclear cell transplantation

Stem Cell Experimental

Bone marrow mononuclear cells

Criteria 

Inclusion Criteria:

Age18 years-80 years
diagnosed as stroke by clinical and MRI findings

Exclusion Criteria:

presence of respiratory distress
presence of acute infections such as Human Immunodeficient Virus/Hepatitis B Virus/ Hepatitis C Virus
malignancies
acute medical conditions such as respiratory infection, fever
hemoglobin less than 8
bleeding tendency
bone marrow disorder
left ventricular ejection fraction < 30%
pregnancy or breastfeeding
No Results Posted